Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fractionDanielle Rasooly, Jacob Joseph, Eric Farber‐Eger et al.|Nature Cardiovascular Research|2025Cited by 19
Leveraging Large-Scale Biobanks for Therapeutic Target DiscoveryBrian R. Ferolito, Alexandre C. Pereira, Hesam Dashti et al.|medRxiv|2025Cited by 4
Large-scale Mendelian randomization identifies novel pathways as therapeutic targets for heart failure with reduced ejection fraction and with preserved ejection fractionDanielle Rasooly, Juan P. Casas, Claudia Giambartolomei et al.|medRxiv|2024Cited by 0
Leveraging large-scale biobanks for therapeutic target discoveryBrian R. Ferolito, Alexandre C. Pereira, Hesam Dashti et al.|Human Genetics and Genomics Advances|2025Cited by 0